FREE SHIPPING ON ORDERS OVER $150

fda warning bpc-157 compounding pharmacies Regulatory Alert: The Legal Status of in and Clinical Practice – Holt Law BPC-157 Legal Status: FDA Regulations

$25.43

Quantity
- +
Description

Abstract Introduction: Vitamin B 12 deficiency is a growing health concern, affecting millions worldwide

fda warning bpc-157 compounding pharmacies Regulatory Alert: The Legal Status of in and Clinical Practice  Holt Law BPC-157 Legal Status: FDA Regulations

Clinical and pharmacological information on this page is provided for professional reference

fda warning bpc-157 compounding pharmacies Regulatory Alert: The Legal Status of in and Clinical Practice  Holt Law BPC-157 Legal Status: FDA Regulations

Product Specifications: Composition: Water for Injection, USP with 0.9% (9 mg/mL) Benzyl Alcohol, NF (bacteriostatic preservative) Volume: 30mL per sterile vial Container Type: Type I borosilicate glass vial with sterile rubber closure and aluminum overseal pH: 4.5 7.0 (per USP monograph) Osmolality: Hypotonic (approximately 0 mOsm/kg) Sterility Assurance Level: 10 (terminal steam sterilization) Bacterial Endotoxin: Bacterial Endotoxins Test Particulate Matter: Complies with USP Particulate Matter specifications FOR RESEARCH USE ONLY

fda warning bpc-157 compounding pharmacies Regulatory Alert: The Legal Status of in and Clinical Practice  Holt Law BPC-157 Legal Status: FDA Regulations

High-purity BPC-157 (5mg) in a white crystalline form, water-soluble for easy preparation

fda warning bpc-157 compounding pharmacies Regulatory Alert: The Legal Status of in and Clinical Practice  Holt Law BPC-157 Legal Status: FDA Regulations

You may also like

recommand products